跳至主要内容
临床试验/NCT04334902
NCT04334902已完成不适用

An Open Label, Multicenter, Retrospective, Pivotal Trial to Evaluate the Efficacy of Clinical Decision Support System-mPDia for Neurodegenerative Parkinsonism Using MRI Images

Heuron Inc.10 个研究点 分布在 1 个国家目标入组 221 人开始时间: 2020年3月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Heuron Inc.
入组人数
221
试验地点
10
主要终点
Sensitivity of mPDia for the Diagnosis of Neurodegenerative Parkinsonism

研究概览

简要总结

mPDia is a software that has been pre-learned based on a neurodegenerative parkinsonism diagnosis model using Nigrosome 1 MRI images, and clinical decision support system for diagnosing neurodegenerative parkinsonism by automatically analyzing Nigrosome 1 MRI images by assisting the medical team.

The specific aims of this study are to evaluate efficacy of mPDia for neurodegenerative Parkinsonism compared to the sensitivity and specificity levels of 18F FP-CIT PET/CT which is currently used to diagnose neurodegenerative parkinsonism.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • Patients with other brain diseases except parkinsonism
  • Who have anatomical abnormality in MRIs etc.
  • Who have other causes of tremor(e.g., thyroid disease)
  • Patients with lesion in basal ganglia(e.g., vascular parkinsonism, hydrocephalus and Wilson's disease)

结局指标

主要结局

Sensitivity of mPDia for the Diagnosis of Neurodegenerative Parkinsonism

时间窗: At Visit 2 (within 4 weeks after Visit 1)

Sensitivity of mPDia in diagnosing neurodegenerative parkinsonism, based on comparison with the golden standard (final clinical diagnosis determined by specialist groups). Sensitivity was calculated as TP/(TP+FN) Sensitivity: 100 x True positive(TP)/ \[True positive(TP) + False negative(FN)\] (%)

Specificity of mPDia for the Diagnosis of Neurodegenerative Parkinsonism

时间窗: At Visit 2 (within 4 weeks after Visit 1)

Specificity of mPDia in diagnosing neurodegenerative parkinsonism, based on comparison with the golden standard (final clinical diagnosis determined by specialist groups). Specificity was calculated as True Negative / (True Negative + False Positive) Specificity: 100 x True negative(TN)/\[False positive(FP) + True negative(TN)\] (%)

次要结局

未报告次要终点

研究者

发起方
Heuron Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验